{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Mahwah",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "84516",
      "recalling_firm": "Glenmark Pharmaceuticals Inc., USA",
      "address_1": "750 Corporate Dr",
      "address_2": "N/A",
      "postal_code": "07430-2009",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Natiowide",
      "recall_number": "D-0641-2020",
      "product_description": "Glenmark Ranitidine Tablets USP 300 mg Rx Only 30 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bandez, Goa 403513, India   Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ   NDC 68462-249-30",
      "product_quantity": "98,988 bottles",
      "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.",
      "recall_initiation_date": "20191217",
      "center_classification_date": "20200105",
      "report_date": "20200115",
      "code_info": "7701429A  7701522A  7702255A  7704745A  19190456  19190472  19190490"
    }
  ]
}